Gain Therapeutics Inc Share Price Today: Live Updates & Key Insights
Gain Therapeutics Inc share price today is $1.75, up -3.85%. The stock opened at $1.785 against the previous close of $1.82, with an intraday high of $1.805 and low of $1.74.
Gain Therapeutics Inc Share Price Chart
Gain Therapeutics Inc
Gain Therapeutics Inc Share Price Performance
Gain Therapeutics Inc Institutional Holdings
Gain Therapeutics Inc Market Status
Gain Therapeutics Inc Fundamentals
Market Cap 77.63 M
PB Ratio 5.6032
PE Ratio 0.0
Enterprise Value 62.62 M
Total Assets 22.82 M
Volume 471962
Gain Therapeutics Inc Company Financials
About Gain Therapeutics Inc & investment objective
Company Information Gain Therapeutics, Inc., a biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas in Switzerland, Spain, the United States, and Australia. The company's drug discovery platform Magellan discovers novel allosteric binding sites in a disease; identifies proprietary small molecules that bind these sites to modulate protein function; and treats the underlying cause of the disease. Its lead drug candidate is GT-02287, which is currently in a Phase 1b study for the treatment of Parkinson's disease with or without a GBA1 mutation. The company has various small molecule drug candidates, which are in the discovery, research, and preclinical stages for the treatment of dementia with Lewy bodies, Alzheimer's disease, and Gaucher's disease, lysosomal storage disorders, metabolic disorders, and solid tumors. Gain Therapeutics, Inc. was founded in 2017 and is based in Bethesda, Maryland.
Organisation Biotechnology
Employees 20
Industry Biotechnology
CEO Mr. Gene Mack M.B.A.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Gain Therapeutics Inc FAQs
What is the share price of Gain Therapeutics Inc today?
The current share price of Gain Therapeutics Inc is $1.75.
Can I buy Gain Therapeutics Inc shares in India?
Yes, Indian investors can buy Gain Therapeutics Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Gain Therapeutics Inc shares in India?
You can easily invest in Gain Therapeutics Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Gain Therapeutics Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Gain Therapeutics Inc.
Can I buy fractional shares of Gain Therapeutics Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Gain Therapeutics Inc?
Gain Therapeutics Inc has a market cap of $77.63 M.
In which sector does Gain Therapeutics Inc belong?
Gain Therapeutics Inc operates in the Biotechnology sector.
What documents are required to invest in Gain Therapeutics Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Gain Therapeutics Inc?
The PE ratio of Gain Therapeutics Inc is N/A and the PB ratio is 5.60.